Relationship between hyponatremia at hospital admission and cardiopulmonary profile at follow-up in patients with SARS-CoV-2 (COVID-19) infectionObservational Study Published on 2023-03-012023-07-10 Journal: Journal of Endocrinological Investigation [Category] COVID19(2023년), [키워드] Follow-up hyponatremia outcome Pneumonia SARS-CoV-2 (Covid-19) infection SIAD. [DOI] 10.1007/s40618-022-01938-9 PMC 바로가기 [Article Type] Observational Study
Clinical outcomes of hospitalized COVID-19 patients treated with remdesivir: a retrospective analysis of a large tertiary care center in GermanyArticle Published on 2023-02-012023-07-09 Journal: Infection [Category] COVID19(2023년), [키워드] Corticosteroids COVID-19 Mortality outcome Remdesivir SARS-CoV-2 Treatment. [DOI] 10.1007/s15010-022-01841-8 PMC 바로가기
Outcomes and risk factors for death among hospitalized children and adolescents with kidney diseases and COVID-19: an analysis of a nationwide databaseArticle Published on 2023-01-012023-07-09 Journal: Pediatric Nephrology (Berlin, Germany) [Category] COVID19(2023년), [키워드] children COVID-19 Kidney disease outcome Risk factors SARS-CoV-2. [DOI] 10.1007/s00467-022-05588-0 PMC 바로가기
COVID-19 vaccine uptake and effectiveness in adults aged 50 years and older in Wales UK: a 1.2m population data-linkage cohort approach영국 웨일즈에서 50세 이상 성인의 COVID-19 백신 섭취 및 효과: 120만 인구 데이터 연결 코호트 접근법Article Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), SARS, 변종, [키워드] 95%CI Adult affected Alpha approach BNT162b2 ChAdOx1 ChAdOx1 vaccine ChAdOx1 vaccines Characteristics Cohort collected data Coverage COVID-19 COVID-19 vaccine COVID-19 vaccines death Delta dose doses Effectiveness estimate first dose followed by Hospital admission immunization Infection linkage of BNT162b2 Older outcome outcomes PCR positive PCR positive SARS-CoV-2 infection post vaccination predominant SARS-CoV-2 SARS-COV-2 infection schedule second dose Seven strain vaccination vaccination. Vaccine variants Wales [DOI] 10.1080/21645515.2022.2031774 PMC 바로가기 [Article Type] Article
A hybrid discrete-continuum model of immune responses to SARS-CoV-2 infection in the lung alveolar region, with a focus on interferon induced innate responseArticle Published on 2022-12-212022-11-15 Journal: Journal of theoretical biology [Category] COVID19(2023년), SARS, 변종, 치료제, [키워드] adaptive alveolar alveolar cells antibodies antibody antibody concentration baseline Cell cell death Cellular automaton COVID-19 develop diffusion domain Efficacy Future Gas exchange healthy human lung Immune cell immune protection immune response Immunity infected cell Infection initial Innate innate immune Innate immunity innate response Interaction interferon interferons lung alveolar maintain manuscript mechanism Model multiple mechanism outcome Pneumonia produced profiles progression Result RNA copy SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant simulations. Spread Strains submitted switching T cells the SARS-CoV-2 virus two-dimensional type I Viral load virion virions [DOI] 10.1016/j.jtbi.2022.111293 PMC 바로가기
Changes of Routine Hematological Parameters in COVID-19 Patients: Correlation with Imaging Findings, RT-PCR and OutcomeOriginal Article Published on 2022-12-152022-10-29 Journal: Iranian Journal of Pathology [Category] COVID-19, [키워드] Admission age analyses Biochemical parameters Blood change Chest chest imaging Chest tomography Concentration Coronavirus disease 2019 correlated correlation correlations COVID-19 COVID-19 case COVID-19 patient Critical CRP CT-scan demonstrated diagnosed Diagnosis during admission enrolled evaluated expired group hematologic hematology hemoglobin Hospitalized imaging investigated Laboratory LDH less leukocyte lung lung involvement Lymphocytes neutrophil no increase outcome parameter parameters participant Patient patients Platelet platelets count Prognostic value raise researcher respiratory viral routine RT-PCR severity Severity of disease the disease tomography Tomography scanners upper respiratory Viral load WBC were measured White blood cells [DOI] 10.30699/IJP.2021.533645.2675 PMC 바로가기 [Article Type] Original Article
Vaccine effectiveness and duration of protection against symptomatic infections and severe Covid-19 outcomes in adults aged 50 years and over, France, January to mid-December 2021Research article Published on 2022-12-012022-10-05 Journal: Global Epidemiology [Category] 변종, [키워드] Analysis booster booster dose COVID-19 database deaths decrease delta variant Effectiveness ENhance Evolution finding France Hospitalization hospitalizations ICU admission infected individuals information National outcome performed Real-world estimates reduced remained reversed SARS-CoV-2 Spread survival symptomatic symptomatic infection symptomatic infections test-negative design vaccination Vaccine vaccine immunity variant variants waning immunity [DOI] 10.1016/j.gloepi.2022.100076 [Article Type] Research article
COVID-19 treatments approved in the European Union and clinical recommendations for the management of non-hospitalized and hospitalized patientsArticle Published on 2022-12-012022-11-15 Journal: Annals of Medicine [Category] COVID19(2023년), SARS, 진단, 치료제, [키워드] addition affecting alleviate antiviral medication antiviral medicine approved Baricitinib Care caused Clinical practice clinical recommendations Community courses COVID-19 COVID-19 pandemic COVID-19 patient COVID-19 treatment COVID-19 treatments Critical deaths develop disease disorder drug Dyspnea effective effective drugs European European Medicines Agency European Union Evidence guidelines. Health healthcare hospital Hospitalization Hospitalized hospitalized patient hypoxia Intervention involved life-threatening lung involvement management Mild moderate molnupiravir monoclonal antibodies monoclonal antibody Most patient Multiorgan dysfunction New outcome public health recommendation Remdesivir Respiratory failure rheumatoid arthritis SARS-CoV-2 Septic shock severe symptom Symptom the disease the patient therapy Thromboembolism Tocilizumab treat Treatment treatment strategy union vaccination [DOI] 10.1080/07853890.2022.2133162 PMC 바로가기
Signs and symptoms of COVID-19 in patients with multiple sclerosisArticle Published on 2022-12-012022-11-16 Journal: European journal of neurology [Category] COVID19(2023년), SARS, 변종, [키워드] affected Ageusia alcohol Analysis Anosmia anti-CD20 therapy association chest pain clinical collected Comorbidity coronavirus disease COVID-19 COVID-19 symptom COVID-19 symptoms Delta Demyelinating diseases difference disease-modifying treatment Factor flu-like symptom Frequency greater identify Infection investigated joint less Linear regression model multiple sclerosis Neurological disorders neurological disorders. number of symptom Occurrence Odds ratio Older outcome Pain Patient Rash recognize risk factor Shortness of breath SIGN similarity smoke smoker Symptom symptoms of COVID-19 Tachycardia therapeutic approach therapy variant [DOI] 10.1111/ene.15554 PMC 바로가기
COVID-19 breakthrough infections and humoral immune response among BNT162b2 vaccinated healthcare workers in Malaysia말레이시아에서 BNT162b2 백신을 접종한 의료 종사자의 COVID-19 획기적인 감염 및 체액성 면역 반응Article Published on 2022-12-012022-09-11 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, [키워드] 95% CI affected age Anti-S1 Anti-spike antibody Antibody Response antibody titres association Asymptomatic Asymptomatic individuals blood sample Blood samples BNT162b2 booster vaccination breakthrough Breakthrough infection breakthrough infections collected COVID-19 COVID-19 infection delta variant detectable domain geometric mean geometric mean titre GMT HCWs healthcare healthcare worker Healthcare workers humoral humoral immune response Humoral immunity IgG IgG assay individual individuals Infection investigated Malaysia not different notable outcome Participants prospective cohort study Protein response significantly significantly higher Support symptomatic the antibody response vaccination Vaccine vaccine doses vaccine. waned was measured [DOI] 10.1080/22221751.2022.2065936 PMC 바로가기 [Article Type] Article